Zucara Therapeutics Announces Publication of Preclinical Study Demonstrating ZT-01's Ability to Restore Glucagon Release in Type 1 Diabetes
/PRNewswire/ - Zucara Therapeutics Inc., a diabetes life sciences company developing the first once-daily therapeutic to prevent insulin-induced hypoglycemia...
Source: prnewswire.com